S

SpyGlass Pharma Inc
D

SGP

25.460
USD
-0.80
(-3.05%)
قبل الجلسة·25.550USD+0.090(+0.35%)
حجم التداول
3,331
الربح لكل سهم
-3
العائد الربحي
-
P/E
-15
حجم السوق
851,585,545
المقالات
المزيد

العنوان: SpyGlass Pharma Inc

القطاع: الرعاية الصحية
الصناعة: Biotechnology
SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company isdeveloping two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.